Home/ Supplements/ Lysine/ L-Lysine 500 mg

L-Lysine 500 mg

product on market Other (e.g. tea bag) Rexall Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for L-Lysine 500 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Caplet(s)
Serving Size
Amino acid/Protein
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

500 mg
Market median: 500.0mg (159 products)

Other Ingredients

Cellulose Contains Less Than 2% of
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: For adults, take one (1) caplet two times daily, preferably on an empty stomach.

Warnings & Precautions

Keep out of reach of children.

Tamper resistant: Do not use if seal under cap is broken or missing.

As a reminder, discuss the supplements and medications you take with your health care providers.

Warning: If you are pregnant, nursing, taking any medications or have any medical condition, consult your doctor before use.

Discontinue use and consult your doctor if any adverse reactions occur.

Formulation Notes

Important facts you should know Lysine is an essential Amino Acid that cannot be made by the body. Amino Acids perform a variety of functions and form the basis for Protein. Lysine is also used for the health and integrity of the skin and lips.

No gluten, no yeast, no wheat, no milk or milk derivatives, no lactose, no sugar, no preservatives, no soy, no artificial color, no artificial flavor, no sodium.

Additional Information

Store at room temperature and avoid excessive heat.

Since 1903 Collagen and tissue maintenance

Satisfaction 100% Guaranteed

Metadata

Product Details

UPC / SKU3 01220 45523 7
DSLD Entry Date2019-10-23
Product TypeAmino acid/Protein
FormOther (e.g. tea bag)
BrandRexall
DSLD ID207110
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
74
Avg Quality
3
Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Lysine →
Compare

Similar Products

View all Lysine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.